← Back to Clinical Trials
Recruiting NCT06776874
Observational Study to Develop a Predictive Score for Adverse Events Post ERCP
Trial Parameters
Condition Endoscopic Retrograde Cholangiopancreatography
Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study Type OBSERVATIONAL
Phase N/A
Enrollment 981
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-03-24
Completion 2025-12-31
Brief Summary
The main objective of the study is: the identification of independent factors associated with an increased risk of post-ERCP complications. Other objectives are: the development of a predictive model of events post-ERCP adverse events and its validation; geographic validation of a predictive model already published in the literature using data collected during the study and the evaluation of the rate of post-ERCP AEs in the centers involved in the study.
Eligibility Criteria
Inclusion Criteria: * Age \>18 years * Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP * Obtaining informed consent Exclusion Criteria: * None